| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |